Brusselle G, Price D, Gruffydd-Jones K, Miravitlles M, Keininger DL, Stewart R, Baldwin M, Jones RC Int J Chron Obstruct Pulmon Dis 2015; 10: 2207-17. [PubMed][Full Text]
Read moreBlood eosinophil count and prospective annual asthma disease burden: a UK cohort study
Price DB, Rigazio A, Campbell JD, Bleecker ER, Corrigan CJ, Thomas M, Wenzel SE, Wilson AM, Small MB, Gopalan G, Ashton VL, Burden A, Hillyer EV, Kerkhof M, Pavord ID Lancet Respir Med 2015; 3(11): 849–58. [PubMed][Full Text]
Read morePredicting frequent COPD exacerbations using primary care data
Kerkhof M, Freeman D, Jones R, Chisholm A, Price DB; Respiratory Effectiveness Group Int J Chron Obstruct Pulmon Dis 2015; 10: 2439-50. [PubMed][Full Text]
Read morePredicting frequent asthma exacerbations using blood eosinophil count and other patient data routinely available in clinical practice
Price D, Wilson AM, Chisholm A, Rigazio A, Burden A, Thomas M, King C J Asthma Allergy 2016; 9: 1-12. [PubMed][Full Text]
Read moreComparison of serious inhaler technique errors made by device-naïve patients using three different dry powder inhalers: a randomised, crossover, open-label study
Chrystyn H, Price DB, Molimard M, Haughney J, Bosnic-Anticevich S, Lavorini F, Efthimiou J, Shan D, Sims E, Burden A, Hutton C, Roche N BMC Pulm Med 2016; 16(1):12. [PubMed][Full Text]
Read moreCharacteristics of patients making serious inhaler errors with a dry powder inhaler and association with asthma-related events in a primary care setting
Westerik JA, Carter V, Chrystyn H, Burden A, Thompson SL, Ryan D, Gruffydd-Jones K5, Haughney J, Roche N, Lavorini F, Papi A, Infantino A,Roman-Rodriguez M11, Bosnic-Anticevich S, Lisspers K, Ställberg B, Henrichsen SH, van der Molen T, Hutton...
Read moreChanges in initial COPD treatment choice over time and factors influencing prescribing decisions in UK primary care: in UK primary care: a real-world, retrospective, observational
Gruffydd-Jones K, Brusselle G, Jones R, Miravitlles M, Baldwin M, Stewart R, Rigazio A, Davis E, Keininger DL, Price D NPJ Prim Care Respir Med 2016; 26: 16002. [Full Text]
Read moreCost-effectiveness of asthma step-up therapy as an increased dose of extrafine-particle inhaled corticosteroid or add-on long-acting beta2-agonist
Roche N, ColiceG, Israel E, Martin RJ, Dorinsky PM, Postma DS, Guilbert TW, Grigg J, van Aalderen WMC, Barion F, Hillyer EV, Thomas V, Burden A, McQueen RB, Price DB Pulm Ther 2016; 2: 73-89. [Full Text]
Read moreAdd-on LABA in a separate inhaler as asthma step-up therapy versus increased dose of ICS or ICS/LABA combination inhaler
Price DB, Colice G , Israel E , Roche N , Postma DS , Guilbert TW , van Aalderen WMC, Grigg J, Hillyer EV , Thomas V, Martin RJ ERJ Open Res 2016; 2(2). [Full Text]
Read moreComorbidity in severe asthma requiring systemic corticosteroid therapy: cross-sectional data from the Optimum Patient Care Research Database and the British Thoracic Difficult Asthma Registry
Sweeney J, Patterson CC, Menzies-Gow A, Niven RM, Mansur AH, Bucknall C, Chaudhuri R, Price D, Brightling CE, Heaney LG; on behalf of the British Thoracic Society Difficult Asthma Network Thorax 2016; 71(4): 339-46. [PubMed][Full Text]
Read moreMulti-component assessment of chronic obstructive pulmonary disease: an evaluation of the ADO and DOSE indices and the global obstructive lung disease categories in international primary care data sets
Jones RC, Price D, Chavannes NH, Lee AJ, Hyland ME, Ställberg B, Lisspers K, Sundh J, van der Molen T, Tsiligianni I; UNLOCK Group of the IPCRG NPJ Prim Care Respir Med 2016; 26: 16010. [PubMed][Full Text]
Read moreAre pharmacological randomised controlled clinical trials relevant to real-life asthma populations? A protocol for an UNLOCK study from the IPCRG
Lisspers K, Teixeira P, Blom C, Kocks J, Ställberg B, Price D, Chavannes N NPJ Prim Care Respir Med 2016; 26: 16016. [PubMed][Full Text]
Read more